Where I see patients (2)
My reviews
Selected research
-
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
Journal for immunotherapy of cancer
-
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Kidney international
-
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Journal for immunotherapy of cancer
4.9